Evidence map›Paper›PMID 35434682›Full record

ArticleMed (New York, N.Y.)2022

Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection.

Aravind Natarajan, Soumaya Zlitni, Erin F Brooks, Summer E Vance, Alex Dahlen, Haley Hedlin, Ryan M Park, Alvin Han, Danica T Schmidtke, Renu Verma and 8 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Med (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05576714 (Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 Associated Encephalopathy/Encephalitis and Multi-systemic Inflammatory Syndrome in Children), which is not on this map. Cited by 247 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
247citing papers in PubMed, 3 pooled it
41.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05576714 unknown statusnot on this map

Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 Associated Encephalopathy/Encephalitis and Multi-systemic Inflammatory Syndrome in Children

Typeobservational_patient_registrySponsorNational Taiwan University HospitalRan2022 to 2025Enrolled300ConditionsCOVID-19-Associated Encephalitis, Multisystem Inflammatory Syndrome in ChildrenArmsdelineate its prognostic biomarker, host genetic factors, immunopathogenesis and viral pathogenesis
3 · Its place in the literature

Who cites it

247 citing papers in PubMed, 3 syntheses or guidelines pooled it, 419 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

187 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Aravind NatarajanDepartment of Genetics, Stanford University, 269 Campus Dr, CCSR 1155b, Stanford, CA, USA.
Soumaya ZlitniDepartment of Genetics, Stanford University, 269 Campus Dr, CCSR 1155b, Stanford, CA, USA.
Erin F BrooksDepartment of Medicine (Hematology, Blood and Marrow Transplantation), Stanford University, Stanford, CA, USA.
Summer E VanceDepartment of Medicine (Hematology, Blood and Marrow Transplantation), Stanford University, Stanford, CA, USA.
Alex DahlenQuantitative Science Unit, Stanford University, Stanford, CA, USA.
Haley HedlinQuantitative Science Unit, Stanford University, Stanford, CA, USA.
Ryan M ParkDepartment of Genetics, Stanford University, 269 Campus Dr, CCSR 1155b, Stanford, CA, USA.
Alvin HanDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Danica T SchmidtkeDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Renu VermaDepartment of Medicine (Infectious Diseases and Geographic Medicine), Stanford University, Stanford, CA, USA.
Karen B JacobsonDepartment of Medicine (Infectious Diseases and Geographic Medicine), Stanford University, Stanford, CA, USA.
Julie ParsonnetDepartment of Medicine (Infectious Diseases), Stanford University, Stanford, CA, USA.
Hector F BonillaDepartment of Medicine (Infectious Diseases), Stanford University, Stanford, CA, USA.
Upinder SinghDepartment of Medicine (Infectious Diseases and Geographic Medicine), Stanford University, Stanford, CA, USA.
Benjamin A PinskyDepartment of Medicine (Infectious Diseases and Geographic Medicine), Stanford University, Stanford, CA, USA.
Jason R AndrewsDepartment of Medicine (Infectious Diseases and Geographic Medicine), Stanford University, Stanford, CA, USA.
Prasanna JagannathanDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Ami S BhattDepartment of Genetics, Stanford University, 269 Campus Dr, CCSR 1155b, Stanford, CA, USA.
Stanford University · US

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Computational models of naturally acquired immunity to falciparum malariaU01AI150741 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUTTE, ATUL J, GREENHOUSE, BRYAN R · 2020 to 2024
$7.4M
Global Epidemiology of Infectious DiseasesT32AI052073 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud, Stephen Patrick Luby · 2003 to 2026
$4.2M
Culture-free pathogen tracking in hospitalized patientsR01AI143757 · NIAID · STANFORD UNIVERSITY · PI BHATT, AMI SIDDHARTH · 2020 to 2023
$3.0M
Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, SalmonellaR01AI148623 · NIAID · STANFORD UNIVERSITY · PI BHATT, AMI SIDDHARTH · 2019 to 2023
$2.0M
Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6M
Translational Studies of Plasmodium Falciparum Infection DynamicsK23AI076614 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENHOUSE, BRYAN R · 2008 to 2012
$609k
NCATS NIH HHS UL1 TR003142NIAID NIH HHS K23 AI076614NIAID NIH HHS K24 AI144048NIAID NIH HHS R01 AI143757NIAID NIH HHS R01 AI148623NIAID NIH HHS T32 AI052073NIAID NIH HHS U01 AI150741
6 · The paper itself

Abstract

Background: COVID-19 manifests with respiratory, systemic, and gastrointestinal (GI) symptoms. Methods: We analyzed the dynamics of fecal RNA shedding up to 10 months after COVID-19 diagnosis in 113 individuals with mild to moderate disease. We also correlated shedding with disease symptoms. Findings: Fecal SARS-CoV-2 RNA is detected in 49.2% [95% confidence interval, 38.2%-60.3%] of participants within the first week after diagnosis. Whereas there was no ongoing oropharyngeal SARS-CoV-2 RNA shedding in subjects at 4 months, 12.7% [8.5%-18.4%] of participants continued to shed SARS-CoV-2 RNA in the feces at 4 months after diagnosis and 3.8% [2.0%-7.3%] shed at 7 months. Finally, we found that GI symptoms (abdominal pain, nausea, vomiting) are associated with fecal shedding of SARS-CoV-2 RNA. Conclusions: The extended presence of viral RNA in feces, but not in respiratory samples, along with the association of fecal viral RNA shedding with GI symptoms suggest that SARS-CoV-2 infects the GI tract and that this infection can be prolonged in a subset of individuals with COVID-19. Funding: This research was supported by a Stanford ChemH-IMA grant; fellowships from the AACR and NSF; and NIH R01-AI148623, R01-AI143757, and UL1TR003142.

Indexed as

Communicable DiseasesCOVID-19Gastrointestinal DiseasesCOVID-19 TestingFecesHumansLungRNA, ViralSARS-CoV-2RNA, ViralCOVID-19fecal RNAgastrointestinal infectionSARS-CoV-2viral shedding

Identifiers

PMID35434682
PMCPMC9005383
OpenAlexW4224054156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.